Source Natural

29
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE679C01027
  • NSEID:
  • BSEID: 531398
INR
109.65
1.65 (1.53%)
BSENSE

Jun 24, 03:30 PM

BSE+NSE Vol: 877

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 64.57% vs 37.96% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 15.00% vs 23.97% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 199.38% vs -23.07% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 67.23% vs -18.13% in Mar 2024

Compare Profit and Loss Results of Source Natural
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
44.00
83.00
-39.00
-46.99%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
44.00
83.00
-39.00
-46.99%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-1.00
0.00
0.00%
Raw Materials Consumed
34.00
38.00
-4.00
-10.53%
Power & Fuel Cost
0.00
6.00
-6.00
-100.00%
Employee Cost
3.00
11.00
-8.00
-72.73%
Operating Expenses
1.00
6.00
-5.00
-83.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
4.00
-4.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
3.00
-3.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
39.00
71.00
-32.00
-45.07%
Operating Profit (PBDIT) excl Other Income
5.00
11.00
-6.00
-54.55%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
5.00
13.00
-8.00
-61.54%
Interest
0.00
6.00
-6.00
-100.00%
Profit before Depriciation and Tax
4.00
6.00
-2.00
-33.33%
Depreciation
1.00
6.00
-5.00
-83.33%
Profit Before Taxation & Exceptional Items
3.00
0.00
3.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
3.00
0.00
3.00
0%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
2.00
0.00
2.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
11.00
46.00
-35.00
-76.09%
Profit Available for appropriations
14.00
46.00
-32.00
-69.57%
Appropriations
14.00
46.00
-32.00
-69.57%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.51
0.2
4.31
2,155.00%
Profit And Loss - Net Sales
Net Sales 44.92 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 64.57% vs 37.96% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.15 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.00% vs 23.97% in Mar 2024

Profit And Loss - Interest
Interest 0.62 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 199.38% vs -23.07% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 2.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 67.23% vs -18.13% in Mar 2024